An analogous observation was reported in colorectal cancer, where selective ablation of LGR5+ CSCs in organoids leads to initial tumor regression, followed by regrowth driven by LGR5+ CSCs reemerging from the LGR5– population (65). This evidence concerns the gene LGR5 and colorectal cancer.